Last updated: 3 months ago
MediWound Ltd. Launches Phase III Trial for EscharEx® - Key Insights
MediWound Ltd. files Form 6-K on Feb 12, 2025, announcing the VALUE Global Phase III trial for EscharEx® aimed at treating Venous Leg Ulcers, marking a significant milestone.